Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron

Published on November 30, 2021

Moderna has been rallying amid concerns surrounding the omicron variant, which has led to possibilities of a rise in demand for COVID-19 vaccines and boosters.